Neonatal cancer is an uncommon disease that comprises of a broad variety of neoplasms with a wide range of histological characteristics. Almost all kinds of pediatric cancer can affect fetuses and newborns however the presentation and behavior of neonatal tumors differs significantly from that of older children resulting in disparities in diagnosis and treatment. Although the origins of neonatal cancer are unknown, genetic factors are likely to play a role. Other congenital anomalies are also present.
"Childhood cancer" is a broad phrase that refers to a variety of cancers and noncancerous tumors that affect children. Pediatric cancer is another name for childhood cancer. Cancer can develop in any part of the body including the blood and lymphatic systems, the brain and spinal cord (central nervous system), kidneys and other organs and tissues in children.
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates